GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: F027400161 [2] | SAR-443765 | SAR443765
Compound class:
Antibody
Comment: Lunsekimig (SAR443765) is a single chain nanobody that is constructed of five linked antibody (VHH) domains that simultaneously bind the inflammatory targets thymic stromal lymphopoietin (TSLP) and IL-13, and human serum albumin (ALB). The peptide sequence provided in the INN record matches SEQ ID No 1 in patent US11208476 [2], which equates to clone F027400161 therein.
|
Classification ![]() |
|
| Compound class | Antibody |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 12833 | lunsekimig |
Synonyms ![]() |
|
| F027400161 [2] | SAR-443765 | SAR443765 | |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 1488 |
| Other databases | |
| CAS Registry No. | 2770858-49-4 (source: WHO INN record) |
| Search PubMed clinical trials | lunsekimig |
| Search PubMed titles | lunsekimig |
| Search PubMed titles/abstracts | lunsekimig |